Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 3 of about 3   

Articles published

NVS 99.80 +1.34 (1.36%)
price chart
New pharmacovigilance system debuts in EU
New rules governing the monitoring, identification and assessment of adverse events caused by pharmaceuticals are introduced, with the aim of making the EU-wide system for overseeing drug safety and 'benefit-risk' more transparent and robust.
5 Excellent Stocks To Start Buying For Retirement: Novartis AG
Novartis AG is a Swiss Healthcare giant, with over half of its revenues derived from pharmaceuticals. A major theme in the pharmaceutical space has been the "perfect storm" of blockbuster drugs losing patent protection, exposing major pipeline ...
Dr. Reddys Launches Generic Lipitor
Other launches include Dr. Reddy's generic version of Novartis AG's (NVS - Analyst Report) over-the-counter (OTC) drug, Prevacid and Bristol-Myers Squibb & Co.